InsiderClue
Stocks · Health care · Biological Products, (No Diagnostic Substances)

Biogen

BIIB Clue Score50
United States Fiscal year ends December CIK 0000875045 Results filed 28 Oct 2026
Add to watchlist

What the insiders did Net buying

Individual transactions

7
Insider
Date
Role
Action
Shares
Price
Amount
Priya Singhal
16 Feb 2024
Head of Development
Sold after exercise
108
$221.49
$23.92K
Stephen A Sherwin
11 Mar 2020
Director
Sold after exercise
270
$295.29
$79.73K
Stephen A Sherwin
11 Mar 2020
Director
Sold after exercise
2,164
$295.22
$638.85K
Robert W Pangia
18 Mar 2019
Director
Sold after exercise
6,114
$328.55
$2.01M
Alfred Sandrock
23 Feb 2018
EVP, Chief Medical Officer
Sold after exercise
908
$293.44
$266.44K
Robert W Pangia
9 Jan 2018
Director
Sold after exercise
5,832
$329.65
$1.92M
Robert W Pangia
9 Jan 2017
Director
Sold after exercise
5,450
$295.39
$1.61M
Show all 73 transactions →

What was left out

Form 4 filings counted 436
Amendments (4/A) skipped 1
Filings about a different issuer 9
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 19
Sales straight out of an exercise 7
Sales at will 20
Transactions with no price 0
Shares from compensation/vesting 939,117
Sales filed before the plan box existed 19
History held since 3 Oct 2006